New study aims to create clearer cancer education for hispanic patients
NCT ID NCT07142005
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study will adapt educational materials about medullary thyroid cancer to be more culturally appropriate and easier to understand for Spanish-speaking Hispanic or Latino patients. Researchers will interview 40 participants, including patients and caregivers, to gather feedback. The goal is to design better resources that help people make informed decisions about their care.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better, culturally tailored educational resources that help Spanish-speaking patients understand medullary thyroid cancer more clearly.
- What could go wrong
- This is a small, early-stage study focused on adapting materials, not testing a treatment. It may not result in widely usable tools or directly improve health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CULTURAL ADAPTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive database study probes link between popular diabetes drugs and rare thyroid cancer
- New program aims to save native moms' lives by blending substance use care with cultural support.
- New imaging agent could improve detection of rare cancers
- New hope for advanced thyroid cancer: drug shows tumor-shrinking promise
- New radioactive therapy targets hard-to-treat thyroid cancer
- New hope for rare cancers? drug combo shows promise in early trial